The store will not work correctly when cookies are disabled.
N-(2-chlorophenyl)imidazo[1,2-a]pyridine-3-carboxamide
ID: ALA1078738
PubChem CID: 46882706
Max Phase: Preclinical
Molecular Formula: C14H10ClN3O
Molecular Weight: 271.71
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccccc1Cl)c1cnc2ccccn12
Standard InChI: InChI=1S/C14H10ClN3O/c15-10-5-1-2-6-11(10)17-14(19)12-9-16-13-7-3-4-8-18(12)13/h1-9H,(H,17,19)
Standard InChI Key: JSSQMMQMSYMBTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-5.6095 -20.8403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6106 -21.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8958 -22.0806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8976 -20.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1822 -20.8367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1774 -21.6631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3900 -21.9140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.9081 -21.2425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3978 -20.5769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3808 -19.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6589 -19.3544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0876 -19.3284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0726 -18.5036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3462 -18.1076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3308 -17.2836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0360 -16.8645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7624 -17.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7742 -18.0838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4948 -18.4856 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9 5 1 0
4 1 2 0
9 10 1 0
5 6 1 0
10 11 2 0
10 12 1 0
2 3 2 0
12 13 1 0
3 6 1 0
13 14 2 0
1 2 1 0
14 15 1 0
5 4 1 0
15 16 2 0
6 7 2 0
16 17 1 0
7 8 1 0
17 18 2 0
18 13 1 0
8 9 2 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 271.71 | Molecular Weight (Monoisotopic): 271.0512 | AlogP: 3.24 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.38 | CX LogP: 2.38 | CX LogD: 2.38 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -2.34 |
References
1. Qiao L, Choi S, Case A, Gainer TG, Seyb K, Glicksman MA, Lo DC, Stein RL, Cuny GD.. (2009) Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors., 19 (21): [PMID:19783434] [10.1016/j.bmcl.2009.09.010] |